Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on zolbetuximab (IMAB362) in adults with gastric cancer, including pharmacokinetic data and current non-recruiting status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Zolbetuximab (IMAB362) (zolbetuximab)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Pharmacokinetics of Zolbetuximab, Gastric Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING